Bedaquiline Resistance after Effective Treatment of Multidrug-Resistant Tuberculosis, Namibia.
Emerg Infect Dis
; 30(3): 568-571, 2024 Mar.
Article
en En
| MEDLINE
| ID: mdl-38407158
ABSTRACT
Bedaquiline is currently a key drug for treating multidrug-resistant or rifampin-resistant tuberculosis. We report and discuss the unusual development of resistance to bedaquiline in a teenager in Namibia, despite an optimal background regimen and adherence. The report highlights the risk for bedaquiline resistance development and the need for rapid drug-resistance testing.
Palabras clave
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Tuberculosis Resistente a Múltiples Medicamentos
Límite:
Adolescent
/
Humans
País/Región como asunto:
Africa
Idioma:
En
Revista:
Emerg Infect Dis
Asunto de la revista:
DOENCAS TRANSMISSIVEIS
Año:
2024
Tipo del documento:
Article